334 related articles for article (PubMed ID: 29508635)
21. REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine.
Escobar-Morreale HF; Botella-Carretero JI; Escobar del Rey F; Morreale de Escobar G
J Clin Endocrinol Metab; 2005 Aug; 90(8):4946-54. PubMed ID: 15928247
[TBL] [Abstract][Full Text] [Related]
22. Different effects of metformin on hypothalamic-pituitary-thyroid axis activity in levothyroxine-treated and levothyroxine-naïve women with non-autoimmune hypothyroidism.
Krysiak R; Kowalcze K; Okopień B
J Clin Pharm Ther; 2020 Dec; 45(6):1427-1433. PubMed ID: 32822526
[TBL] [Abstract][Full Text] [Related]
23. Design of the Optimal Trial of Combination Therapy.
Cappola AR
Front Endocrinol (Lausanne); 2020; 11():168. PubMed ID: 32318021
[TBL] [Abstract][Full Text] [Related]
24. Optimizing treatment of hypothyroidism.
Clarke N; Kabadi UM
Treat Endocrinol; 2004; 3(4):217-21. PubMed ID: 16026104
[TBL] [Abstract][Full Text] [Related]
25. Sexual Function in Levothyroxine-Treated Hypothyroid Women and Women without Hypothyroidism: A Case-Control.
Romero-Gómez B; Guerrero-Alonso P; Carmona-Torres JM; Laredo-Aguilera JA; Pozuelo-Carrascosa DP; Cobo-Cuenca AI
Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32560383
[No Abstract] [Full Text] [Related]
26. Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial.
Sawka AM; Gerstein HC; Marriott MJ; MacQueen GM; Joffe RT
J Clin Endocrinol Metab; 2003 Oct; 88(10):4551-5. PubMed ID: 14557420
[TBL] [Abstract][Full Text] [Related]
27. Does combination T4 and T3 therapy make sense?
McDermott MT
Endocr Pract; 2012; 18(5):750-7. PubMed ID: 22548953
[TBL] [Abstract][Full Text] [Related]
28. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
29. Use of liothyronine without levothyroxine in the treatment of mild consumptive hypothyroidism caused by hepatic hemangiomas.
Higuchi S; Takagi M; Hasegawa Y
Endocr J; 2017 Jun; 64(6):639-643. PubMed ID: 28420821
[TBL] [Abstract][Full Text] [Related]
30. Combined therapy with levothyroxine and liothyronine for hypothyroidism.
Fischman A; Domínguez JM
Medwave; 2018 Dec; 18(8):e7376. PubMed ID: 30550536
[TBL] [Abstract][Full Text] [Related]
31. Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone.
Rodriguez T; Lavis VR; Meininger JC; Kapadia AS; Stafford LF
Endocr Pract; 2005; 11(4):223-33. PubMed ID: 16006298
[TBL] [Abstract][Full Text] [Related]
32. Use of thyroid hormones in hypothyroid and euthyroid patients: A 2020 THESIS questionnaire survey of members of the Danish Endocrine Society.
Riis KR; Frølich JS; Hegedüs L; Negro R; Attanasio R; Nagy EV; Papini E; Perros P; Bonnema SJ
J Endocrinol Invest; 2021 Nov; 44(11):2435-2444. PubMed ID: 33774809
[TBL] [Abstract][Full Text] [Related]
33. Risks and safety of combination therapy for hypothyroidism.
Jonklaas J
Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1057-67. PubMed ID: 27137849
[TBL] [Abstract][Full Text] [Related]
34. Are We Restoring Thyroid Hormone Signaling in Levothyroxine-Treated Patients With Residual Symptoms of Hypothyroidism?
Casula S; Ettleson MD; Bianco AC
Endocr Pract; 2023 Jul; 29(7):581-588. PubMed ID: 37419565
[TBL] [Abstract][Full Text] [Related]
35. The effect of vitamin D supplementation on sexual functioning and depressive symptoms in young women with low vitamin D status.
Krysiak R; Szwajkosz A; Marek B; Okopień B
Endokrynol Pol; 2018; 69(2):168-174. PubMed ID: 29442353
[TBL] [Abstract][Full Text] [Related]
36. Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study.
Krysiak R; Drosdzol-Cop A; Skrzypulec-Plinta V; Okopien B
Endocrine; 2016 Jul; 53(1):291-8. PubMed ID: 26902871
[TBL] [Abstract][Full Text] [Related]
37. Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement.
Ahluwalia R; Baldeweg SE; Boelaert K; Chatterjee K; Dayan C; Okosieme O; Priestley J; Taylor P; Vaidya B; Zammitt N; Pearce SH
Clin Endocrinol (Oxf); 2023 Aug; 99(2):206-216. PubMed ID: 37272400
[TBL] [Abstract][Full Text] [Related]
38. Sexual function and depressive symptoms in young women with low vitamin D status: a pilot study.
Krysiak R; Gilowska M; Okopień B
Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():108-12. PubMed ID: 27544743
[TBL] [Abstract][Full Text] [Related]
39. Persistent hyperthyrotropinemia in congenital hypothyroidism: successful combination treatment with levothyroxine and liothyronine.
Strich D; Naugolny L; Gillis D
J Pediatr Endocrinol Metab; 2011; 24(5-6):347-50. PubMed ID: 21823534
[TBL] [Abstract][Full Text] [Related]
40. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial.
Bolk N; Visser TJ; Nijman J; Jongste IJ; Tijssen JG; Berghout A
Arch Intern Med; 2010 Dec; 170(22):1996-2003. PubMed ID: 21149757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
